<?xml version="1.0" encoding="UTF-8"?>
<p>First isolated from an outbreak in Tanzania in 1952, Chikungunya derives its name from the Tanzanian Makonde dialect that means “that which bends up”, referring to the posture of patients afflicted with extreme joint pain, which is a distinguishing trait of the illness [
 <xref rid="B56-molecules-25-02796" ref-type="bibr">56</xref>,
 <xref rid="B57-molecules-25-02796" ref-type="bibr">57</xref>,
 <xref rid="B58-molecules-25-02796" ref-type="bibr">58</xref>]. Since 1952, CHIKV has caused a few sporadic outbreaks, mainly in Africa, Southeast Asia and India, many of them involving hundreds of thousands of people [
 <xref rid="B58-molecules-25-02796" ref-type="bibr">58</xref>,
 <xref rid="B59-molecules-25-02796" ref-type="bibr">59</xref>,
 <xref rid="B60-molecules-25-02796" ref-type="bibr">60</xref>]. CHIKV only attracted worldwide attention when it caused an explosive outbreak in 2005–2006 on the French island of La Réunion (population: 770,000) infecting 40% of its inhabitants and resulting in more than 250 fatalities [
 <xref rid="B61-molecules-25-02796" ref-type="bibr">61</xref>,
 <xref rid="B62-molecules-25-02796" ref-type="bibr">62</xref>]. CHIKV is transmitted by 
 <italic>Aedes</italic> mosquitoes and causes CHIK fever, which is accompanied by headache, maculopapular rash, back pain, myalgia, and polyarthralgia [
 <xref rid="B57-molecules-25-02796" ref-type="bibr">57</xref>,
 <xref rid="B63-molecules-25-02796" ref-type="bibr">63</xref>]. Complications of CHIKV infection include respiratory failure and meningoencephalitis [
 <xref rid="B13-molecules-25-02796" ref-type="bibr">13</xref>]. Some patients have been reported to experience recurrent and persistent myalgia and arthralgia which last for weeks to months even after recovery, resulting in long-term disability [
 <xref rid="B56-molecules-25-02796" ref-type="bibr">56</xref>,
 <xref rid="B60-molecules-25-02796" ref-type="bibr">60</xref>,
 <xref rid="B64-molecules-25-02796" ref-type="bibr">64</xref>]. However, there is currently no approved antiviral treatment or vaccine for CHIKV infection; treatment is usually symptomatic [
 <xref rid="B65-molecules-25-02796" ref-type="bibr">65</xref>]. To date, CHIKV has been detected in more than 40 countries, including Indonesia, Thailand, Singapore, Cambodia, India, USA, Italy, and France [
 <xref rid="B66-molecules-25-02796" ref-type="bibr">66</xref>,
 <xref rid="B67-molecules-25-02796" ref-type="bibr">67</xref>,
 <xref rid="B68-molecules-25-02796" ref-type="bibr">68</xref>,
 <xref rid="B69-molecules-25-02796" ref-type="bibr">69</xref>,
 <xref rid="B70-molecules-25-02796" ref-type="bibr">70</xref>].
</p>
